SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-012377
Filing Date
2023-04-14
Accepted
2023-04-14 17:21:14
Documents
17
Period of Report
2023-04-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41063
2 ex1-1.htm EX-1.1 293248
3 ex5-1.htm EX-5.1 17276
4 ex5-1_001.jpg GRAPHIC 23195
5 ex5-1_002.jpg GRAPHIC 7717
6 ex5-1_003.jpg GRAPHIC 12720
  Complete submission text file 0001493152-23-012377.txt   651140

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE brtx-20230414.xsd EX-101.SCH 3245
8 XBRL LABEL FILE brtx-20230414_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE brtx-20230414_pre.xml EX-101.PRE 22371
11 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3491
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

IRS No.: 911835664 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37603 | Film No.: 23822104
SIC: 8090 Services-Misc Health & Allied Services, NEC